| scholarly article | Q13442814 |
| P50 | author | Myra McClure | Q59550553 |
| P2093 | author name string | N Robinson | |
| S Kaye | |||
| M Carrington | |||
| J Weber | |||
| J Fox | |||
| A J Frater | |||
| A Duda | |||
| A R McLean | |||
| H Fryer | |||
| L Lee-Turner | |||
| R E Phillips | |||
| S Dustan | |||
| S Fidler | |||
| SPARTAC Trial Investigators | |||
| P2860 | cites work | Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection | Q24536249 |
| Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection | Q24645815 | ||
| Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome | Q24648628 | ||
| Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo | Q25255777 | ||
| HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage | Q28138607 | ||
| 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults | Q28184343 | ||
| Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS | Q28198471 | ||
| Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases | Q28288689 | ||
| HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells | Q29616205 | ||
| Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes | Q29616210 | ||
| Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection | Q29619510 | ||
| HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. | Q33262230 | ||
| Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1 | Q33290217 | ||
| Cytotoxic T-lymphocyte responses to HIV-1 reverse transcriptase (review). | Q33585658 | ||
| Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines | Q34053246 | ||
| Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS | Q34339925 | ||
| Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. | Q34468117 | ||
| Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1 | Q34545760 | ||
| Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover | Q34692601 | ||
| HIV: current opinion in escapology | Q34772244 | ||
| Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution | Q35634318 | ||
| In vivo CD8+ T cell control of immunodeficiency virus infection in humans and macaques | Q35748658 | ||
| Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression | Q35857259 | ||
| Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. | Q36376216 | ||
| Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA. | Q36403330 | ||
| Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child | Q36684112 | ||
| HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load | Q36748059 | ||
| Central role of reverting mutations in HLA associations with human immunodeficiency virus set point | Q36845904 | ||
| Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection | Q36898637 | ||
| Special anniversary review: twenty-five years of human immunodeficiency virus research: successes and challenges | Q37121901 | ||
| Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection | Q39594576 | ||
| Passive sexual transmission of human immunodeficiency virus type 1 variants and adaptation in new hosts | Q41494621 | ||
| Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. | Q44291572 | ||
| Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus | Q44584141 | ||
| Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection. | Q44605635 | ||
| Identification of multiple HIV-1 CTL epitopes presented by HLA-B*5101 molecules | Q45094092 | ||
| Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3. | Q47300875 | ||
| Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection. | Q53308172 | ||
| Founder Effects in the Assessment of HIV Polymorphisms and HLA Allele Associations | Q56880587 | ||
| CD8+ T-cell responses to different HIV proteins have discordant associations with viral load | Q57259602 | ||
| Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: findings from an observational cohort | Q59119659 | ||
| HIV-1 Epitope-Specific CD8+ T Cell Responses Strongly Associated with Delayed Disease Progression Cross-Recognize Epitope Variants Efficiently | Q61053915 | ||
| Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS | Q73034306 | ||
| Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS | Q73326167 | ||
| Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level | Q74171545 | ||
| HLA and AIDS: a cautionary tale | Q74446693 | ||
| AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis | Q81481381 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1228-1239 | |
| P577 | publication date | 2008-11-19 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection | |
| P478 | volume | 83 |
| Q34057942 | Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial |
| Q31010282 | CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope |
| Q92701175 | Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure |
| Q59360481 | Computational comparison of availability in CTL/gag epitopes among patients with acute and chronic HIV-1 infection |
| Q36467153 | Conservation of HIV-1 T cell epitopes across time and clades: validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccine |
| Q42211756 | Cytotoxic T-lymphocyte escape mutations identified by HLA association favor those which escape and revert rapidly |
| Q35140263 | Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes |
| Q34308788 | Early immune adaptation in HIV-1 revealed by population-level approaches |
| Q34295972 | Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection |
| Q41119832 | Effects of neutralizing antibodies on escape from CD8+ T-cell responses in HIV-1 infection |
| Q35535663 | Evolutionary gamut of in vivo Gag substitutions during early HIV-1 subtype C infection |
| Q34295981 | Fluidity of HIV-1-specific T-cell responses during acute and early subtype C HIV-1 infection and associations with early disease progression |
| Q56999671 | Further progress on defining highly conserved immunogenic epitopes for a global HIV vaccine: HLA-A3-restricted GAIA vaccine epitopes |
| Q35156765 | Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemic |
| Q34653619 | HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice |
| Q33642318 | HIV-1 vaccine development after STEP. |
| Q41058978 | HLA B51 is associated with faster AIDS progression among newly diagnosed HIV-infected individuals in Manitoba, Canada. |
| Q33494829 | HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins |
| Q35076519 | Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C. |
| Q35567805 | Key role of human leukocyte antigen in modulating human immunodeficiency virus progression: An overview of the possible applications |
| Q37738467 | Low level of HIV-1 evolution after transmission from mother to child |
| Q30992754 | Modelling the evolution and spread of HIV immune escape mutants |
| Q84193741 | Novel HIV-1 clade B candidate vaccines designed for HLA-B*5101(+) patients protected mice against chimaeric ecotropic HIV-1 challenge |
| Q30404569 | Phylogenetic analysis consistent with a clinical history of sexual transmission of HIV-1 from a single donor reveals transmission of highly distinct variants |
| Q36481449 | Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemic |
| Q34841789 | Progression to AIDS in South Africa is associated with both reverting and compensatory viral mutations |
| Q41279465 | Rapid human immunodeficiency virus disease progression is associated with human leukocyte antigen-B homozygocity and human leukocyte antigen-B51 in a cohort from Manitoba, Canada. |
| Q33910862 | Reversion and T cell escape mutations compensate the fitness loss of a CD8+ T cell escape mutant in their cognate transmitted/founder virus |
| Q35099081 | Structured observations reveal slow HIV-1 CTL escape |
| Q33515034 | Timing constraints of in vivo gag mutations during primary HIV-1 subtype C infection |
| Q42549345 | Tracking the culprit: HIV-1 evolution and immune selection revealed by single-genome amplification |
Search more.